Related Experiment Video
Updated: Sep 9, 2025

10:21
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.9K
Glycyrrhizic acid: novel potential protein targets
P V Ershov1, E O Yablokov1, L A Kaluzhskiy1
1Institute of Biomedical Chemistry, Moscow, Russia.
Biomeditsinskaia Khimiia
|September 4, 2025
Summary
Glycyrrhizic acid (GA) interacts with 88 liver proteins, revealing its molecular mechanisms. This study identifies key protein targets involved in cellular metabolism and disease pathways, advancing our understanding of GA
Area of Science:
- Pharmacology and Biochemistry
- Molecular Biology
- Proteomics
Background:
- Glycyrrhizic acid (GA), a natural glycoside, exhibits biological activity, but its molecular mechanisms remain incompletely understood.
- Identifying protein targets of GA is crucial for elucidating its pharmacodynamics and potential therapeutic applications.
Purpose of the Study:
- To experimentally identify the tissue-specific protein targets interacting with GA in a rat liver model.
- To investigate the molecular interactions and cellular functions of GA-binding proteins.
Main Methods:
- Affinity chromatography using GA immobilized on EAH-Sepharose 4B to isolate interacting proteins from rat liver lysate.
- Mass spectrometry for identification of potential protein targets.
- Gel chromatography and semi-quantitative analysis to assess GA's influence on specific proteins (Aldh6a1, Decr1, Sod1).
- Molecular docking simulations (Flare™) to model protein-GA complexes and evaluate binding affinity (ΔG, Rank score) for selected proteins (Acox2, Acr1c9, Maoa, Mat1a, Nalcn).
Main Results:
- Identified 88 potential protein targets interacting with GA in rat liver tissue.
- GA demonstrated influence on Aldh6a1, Decr1, and Sod1 proteins.
- Molecular docking identified 5 proteins (Acox2, Acr1c9, Maoa, Mat1a, Nalcn) with favorable binding parameters.
- Over half (57%) of the identified proteins are involved in cellular metabolism and biotransformation processes.
Conclusions:
- This study provides a comprehensive list of potential GA protein targets in the liver, contributing to understanding its molecular action.
- The identified targets, particularly those involved in metabolism, offer insights into GA's diverse biological activities and disease associations.
- Further research into these protein-GA interactions can pave the way for novel therapeutic strategies involving glycyrrhizic acid.
Related Concept Videos
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Protein Glycosylation
7.2K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.2K
G Protein-coupled Receptors
13.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.3K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Protein-protein Interfaces
13.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K

